iBio Inc (IBIO)
2.10
+0.03
(+1.45%)
USD |
NYAM |
Jun 27, 16:00
2.08
-0.02
(-0.95%)
After-Hours: 20:00
iBio Net Income (Annual): -65.01M for June 30, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| June 30, 2023 | -65.01M |
| June 30, 2022 | -50.39M |
| June 30, 2021 | -23.21M |
| June 30, 2020 | -16.44M |
| June 30, 2019 | -17.59M |
| June 30, 2018 | -16.10M |
| June 30, 2017 | -14.53M |
| June 30, 2016 | -9.764M |
| June 30, 2015 | -6.625M |
| Date | Value |
|---|---|
| June 30, 2014 | -3.666M |
| June 30, 2013 | -6.198M |
| June 30, 2012 | -5.676M |
| June 30, 2011 | -12.14M |
| June 30, 2010 | -6.078M |
| June 30, 2009 | -1.907M |
| June 30, 2008 | -1.869M |
| June 30, 2007 | -1.666M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-65.01M
Minimum
2023
-16.44M
Maximum
2020
-34.53M
Average
-23.21M
Median
2021
Net Income (Annual) Benchmarks
| Lixte Biotechnology Holdings Inc | -5.087M |
| PAVmed Inc | -64.18M |
| Avalo Therapeutics Inc | -31.54M |
| Imunon Inc | -19.52M |
| Ocugen Inc | -63.08M |